| Patents for C12P 21 - Preparation of peptides or proteins (112,499) |
|---|
| 07/13/1999 | US5922841 Recombinantly produced transferrin receptor of haemophilus |
| 07/13/1999 | US5922602 This invention is in the field of gene regulation through anti-sense rna endogenously produced inhibitory rna molecules such as anti-sense rna and co-suppressor rna. |
| 07/13/1999 | US5922595 Cyclic GMP phosphodiesterase |
| 07/13/1999 | US5922590 Hic-1 is a marker which can be used diagnostically, prognostically and therapeutically over the course of such disorders. |
| 07/13/1999 | US5922572 Polynucleotides encoding haemopoietic maturation factor |
| 07/13/1999 | US5922569 Process for the production of polypeptides |
| 07/13/1999 | US5922566 Polynucleotide |
| 07/13/1999 | US5922564 Phosphate-deficiency inducible promoter |
| 07/13/1999 | US5922562 Nucleic acids encoding transferrin receptors |
| 07/13/1999 | US5922561 Genes encoding signal recognition particle of Aspergillus niger |
| 07/13/1999 | US5922549 Process for screening substances having a modulating effect on an interleukin-5 receptor mediated cellular signal transmission pathway |
| 07/13/1999 | US5922546 Human disintegrin metalloprotease KUZ gene |
| 07/13/1999 | US5922541 Method for detection of PF4A receptor nucleic acid |
| 07/13/1999 | US5922329 Immunity against giardia from vaccine from isolation of exotoxin |
| 07/13/1999 | US5922325 Synergistic neutralization of HIV-1 by human monoclonal antibodies and other antibodies directed against the v3 loop and the CD-4 binding site of GP-120,and the use for immunotherapy of HIV-1 infection |
| 07/13/1999 | US5922323 Transferrin receptor genes and immunogenic compositions derived therefrom |
| 07/13/1999 | CA2121257C Stabilised antibodies |
| 07/13/1999 | CA1340650C Artificial gene coding for authentic human serum albumin, use thereof, and method of producing the same |
| 07/13/1999 | CA1340649C Purified follicle stimulating hormone |
| 07/13/1999 | CA1340643C Thermally stable and ph stable subtilisin analogs and method for production thereof |
| 07/13/1999 | CA1340641C Recombinant lymphotoxin |
| 07/08/1999 | WO1999033989A2 Rantes mutants and therapeutic applications thereof |
| 07/08/1999 | WO1999033988A1 A process for preparing human proinsulin |
| 07/08/1999 | WO1999033984A1 V197 dna and polypeptides |
| 07/08/1999 | WO1999033983A1 V201 dna and polypeptides |
| 07/08/1999 | WO1999033981A2 Human signal peptide-containing proteins |
| 07/08/1999 | WO1999033978A1 Novel guanosine triphosphate (gtp)-binding protein conjugate type receptor proteins |
| 07/08/1999 | WO1999033975A1 Heat shock transcription factor-binding protein |
| 07/08/1999 | WO1999033968A1 Process for producing antibody catalyst and method for utilizing the antibody catalyst thus obtained |
| 07/08/1999 | WO1999033878A1 Monoclonal antibody against connective tissue growth factor and medicinal uses thereof |
| 07/08/1999 | WO1999033877A1 V196 dna and polypeptides |
| 07/08/1999 | WO1999033876A1 Novel seven-pass transmembrane receptor protein |
| 07/08/1999 | WO1999033873A1 NOVEL POLYPEPTIDES, cDNAS ENCODING THE SAME AND UTILIZATION THEREOF |
| 07/08/1999 | WO1999033871A2 Essential bacterial genes and their use |
| 07/08/1999 | WO1999033870A2 Human regulatory proteins |
| 07/08/1999 | WO1999033869A2 Compounds for immunotherapy and diagnosis of breast cancer and methods for their use |
| 07/08/1999 | WO1999021976A3 Rapid generation of stable mammalian cell lines producing high levels of recombinant proteins |
| 07/08/1999 | WO1999005288A3 Method for producing and identifying new hydrolases having improved properties |
| 07/08/1999 | WO1999004265A9 Cancer associated nucleic acids and polypeptides |
| 07/08/1999 | CA2316397A1 Compounds for immunotherapy and diagnosis of breast cancer and methods for their use |
| 07/08/1999 | CA2316283A1 Novel guanosine triphosphate (gtp) binding protein-coupled receptor protein |
| 07/08/1999 | CA2316079A1 Human regulatory proteins |
| 07/08/1999 | CA2316016A1 V197 dna and polypeptides |
| 07/08/1999 | CA2315879A1 V201 dna and polypeptides |
| 07/08/1999 | CA2315750A1 A process for preparing human proinsulin |
| 07/08/1999 | CA2315702A1 V196 dna and polypeptides |
| 07/08/1999 | CA2315617A1 Human signal peptide-containing proteins |
| 07/08/1999 | CA2315252A1 Essential bacterial genes and their use |
| 07/07/1999 | EP0927763A2 Novel aroA |
| 07/07/1999 | EP0927758A2 Recombinant antibodies specific for TNF-Alpha |
| 07/07/1999 | EP0927354A1 DIAGNOSTIC METHOD FOR DETECTION OF MOLECULAR FORMS OF EOSINOPHILIC CATIONIC PROTEIN (iso-ECPs) |
| 07/07/1999 | EP0927266A1 THE $i(ESCHERICHIA COLI csrB) GENE, RNA ENCODED THEREBY, AND METHODS OF USE THEREOF |
| 07/07/1999 | EP0927260A1 In vivo protein synthesis method |
| 07/07/1999 | EP0927252A1 Antibodies against interferon alpha/beta receptor |
| 07/07/1999 | EP0927247A1 Cell-free translational extract from eukaryotic cells that have grown in monolayers |
| 07/07/1999 | EP0927046A1 Mammalian regulator of nonsense-mediated rna decay |
| 07/07/1999 | EP0637336B1 Mn gene and protein |
| 07/07/1999 | EP0537166B1 Water-soluble polypeptides having high affinity for interferons alpha and beta |
| 07/07/1999 | CN1222193A Extracellular matrix signalling molecules |
| 07/07/1999 | CN1222081A Method for prevention and treatment of mastitis |
| 07/07/1999 | CN1221880A In vitro method for determining presence of hepatocellular carcindoma |
| 07/07/1999 | CN1221879A In vitro method for determining presence of hepatocellular carcindoma |
| 07/07/1999 | CN1221752A Novel lantibiotic related to actagardine, and process for preparation and use thereof |
| 07/06/1999 | US5919918 Antimicrobial protein capable of isolation from seeds of heuchera or aesculus |
| 07/06/1999 | US5919911 Monoclonal antibodies to stem cell factor receptors |
| 07/06/1999 | US5919910 Monoclonal antibodies |
| 07/06/1999 | US5919906 High gel strength, clear photographic gelatin enzymatically extracted from collagen |
| 07/06/1999 | US5919905 Cytokine designated LERK-6 |
| 07/06/1999 | US5919904 Response regulator polypeptides; screening for bactericides |
| 07/06/1999 | US5919903 Low affinity human IL-12 beta2 receptor |
| 07/06/1999 | US5919899 Wound healing agents for burns, injuries, and surgeries; antiulcer agents; antiinflammatory agents; markers in diagnosis of tumors |
| 07/06/1999 | US5919896 PF4A receptor |
| 07/06/1999 | US5919895 Secretion of hirudin derivatives |
| 07/06/1999 | US5919702 Collecting wharton's jelly from umbilical cords, culturing so that pre-chondrocytes proliferate, isolating pre-chondrocytes which give rise to chondrocytes which produce cartilage tissue for therapeutic use |
| 07/06/1999 | US5919699 Amino acid transporters and uses |
| 07/06/1999 | US5919693 Nucleic acid sequences of heparinases ii and iii, and transformed cells expressing heparinase ii and iii; degrade heparin and heparin sulfate |
| 07/06/1999 | US5919692 Ubiquitous ATP-sensitive potassium-channel genes |
| 07/06/1999 | US5919676 Isolated cell concurrently infected with helper adenovirus with packaging signals flanked by recombinase sites and replication/packaging competant helper-dependent vector with deletion to 35,000 base pairs for insertion of exogenous dna |
| 07/06/1999 | US5919664 For screening for antibacterial compounds |
| 07/06/1999 | US5919662 Producing biotin and/or desthiobiotin at high yield by culturing to high density escherichia coli strain containing recombinant plasmid with biotin operon; less growth inhibition by build-up of acetate in media |
| 07/06/1999 | US5919660 Human requiem |
| 07/06/1999 | US5919659 Polynucleotide |
| 07/06/1999 | US5919653 A recombinantly altered nucleotide sequence that codes for a neurotransmitter protein; treatment of epilepsy, stroke, multiple sclerosis, spinal cord injury, and other nervous system disorders |
| 07/06/1999 | US5919651 Expression of polypeptides in yeast |
| 07/06/1999 | US5919637 Method for identifying reduced binding between GMP-140 and GMP-140 ligand |
| 07/06/1999 | US5919636 Genetic engineered human embryonic kidney cells containing mammmalian scavenger gene |
| 07/06/1999 | US5919635 Using a genetic engineered receptor |
| 07/06/1999 | US5919628 Amino acid transporters and uses |
| 07/06/1999 | US5919619 Preferentally suppressing gene expression of target proteins by synthesizing and then hybridizing complementary oligonucleotide to subsequence of specific messenger ribonucleic acid in cell |
| 07/06/1999 | US5919615 Polypeptides and antibodies characteristic of papillomavirus, and diagnostic procedures and vaccines making use of them |
| 07/06/1999 | US5919457 Immunoconjugates comprising the monoclonal antibody txu-5/b53 linked to pokeweed antiviral protein or bioactive subunits thereof are provided which are effective for the treatment of mammalian hiv infection. |
| 07/06/1999 | US5919454 Nucleotide and peptide sequences of a hepatitis C virus isolate, diagnostic and therapeutic applications |
| 07/06/1999 | US5919453 Monoclonal antibodies against the interferon receptor, with neutralizing activity against type I interferon |
| 07/06/1999 | CA2098397C Physiologically active substance designated as epimorphin, genes encoding the same, and antibodies thereto |
| 07/06/1999 | CA2058785C Method of producing proteins with fviii activity and/or fviii derivatives |
| 07/06/1999 | CA2000604C Process for the activation of genetechnologically produced, biologically-active proteins expressed in prokaryotes |
| 07/06/1999 | CA1340627C T4 glycoprotien fragments and use of fragments of t4 in the treatment of aids |
| 07/06/1999 | CA1340625C Cloned cardionatrin cdna |
| 07/06/1999 | CA1340624C Modified vaccinia virus and methods for making and using the same |
| 07/05/1999 | WO1999038976A2 Human growth factor homologs |